# Ultherapy™ Treatment Following Sculptra® Treatment

> **NCT01422538** · NA · COMPLETED · sponsor: **Ulthera, Inc** · enrollment: 30 (actual)

## Conditions studied

- Skin Laxity

## Interventions

- **DEVICE:** Ulthera® System
- **DRUG:** Sculptra®
- **OTHER:** Sculptra® treatment followed by Ultherapy™ treatment

## Key facts

- **NCT ID:** NCT01422538
- **Lead sponsor:** Ulthera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-06
- **Final completion:** 2012-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422538

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422538, "Ultherapy™ Treatment Following Sculptra® Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01422538. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*